Sera Prognostics, Inc. (SERA)
2.18
+0.04
(+1.87%)
USD |
NASDAQ |
Aug 24, 16:00
2.15
-0.03
(-1.38%)
After-Hours: 20:00
Sera Prognostics Shareholders Equity (Quarterly) : 59.38M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.38M |
| March 31, 2026 | 67.62M |
| December 31, 2025 | 75.41M |
| September 30, 2025 | 82.18M |
| June 30, 2025 | 88.23M |
| March 31, 2025 | 94.78M |
| December 31, 2024 | 47.80M |
| September 30, 2024 | 54.65M |
| June 30, 2024 | 59.75M |
| March 31, 2024 | 64.75M |
| December 31, 2023 | 70.16M |
| September 30, 2023 | 75.41M |
| Date | Value |
|---|---|
| June 30, 2023 | 81.14M |
| March 31, 2023 | 90.21M |
| December 31, 2022 | 98.94M |
| September 30, 2022 | 107.16M |
| June 30, 2022 | 116.90M |
| March 31, 2022 | 127.20M |
| December 31, 2021 | 138.56M |
| September 30, 2021 | 150.04M |
| June 30, 2021 | -135.80M |
| March 31, 2021 | -130.39M |
| December 31, 2020 | -125.57M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| CareDx, Inc. | 425.60M |
| Natera, Inc. | 1.821B |
| Exagen, Inc. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.74M |
| Total Liabilities (Quarterly) | 27.36M |
| Debt to Equity Ratio | 0.0505 |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | -0.68% |